Related Experiment Video
Updated: Dec 12, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Tristetraprolin Posttranscriptionally Downregulates TRAIL Death Receptors
Won Hyeok Lee1,2, Myung Woul Han1,2, Song Hee Kim1,2
1Department of Otorhinolaryngology, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 44033, Korea.
Abstract:
Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) has attracted attention as a potential candidate for cancer therapy. However, many primary cancers are resistant to TRAIL, even when combined with standard chemotherapy. The mechanism of TRAIL resistance in cancer cells has not been fully elucidated. The TRAIL death receptor (DR) 3'-untranslated region (3'-UTR) is reported to contain AU-rich elements (AREs) that are important for regulating DR mRNA stability. However, the mechanisms by which DR mRNA stability is determined by its 3'-UTR are unknown. We demonstrate that tristetraprolin (TTP), an ARE-binding protein, has a critical function of regulating DR mRNA stability. DR4 mRNA contains three AREs and DR5 mRNA contains four AREs in 3'-UTR. TTP bound to all three AREs in DR4 and ARE3 in DR5 and enhanced decay of DR4/5 mRNA. TTP overexpression in colon cancer cells changed the TRAIL-sensitive cancer cells to TRAIL-resistant cells, and down-regulation of TTP increased TRAIL sensitivity via DR4/5 expression. Therefore, this study provides a molecular mechanism for enhanced levels of TRAIL DRs in cancer cells and a biological basis for posttranscriptional modification of TRAIL DRs. In addition, TTP status might be a biomarker for predicting TRAIL response when a TRAIL-based treatment is used for cancer.
Insights
Tristetraprolin (TTP) regulates cancer cell sensitivity to Tumor Necrosis Factor (TNF)-related apoptosis-inducing ligand (TRAIL) therapy. TTP controls the stability of TRAIL death receptor (DR) mRNA, impacting treatment response.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) shows promise for cancer therapy but faces resistance in many primary cancers.
- The mechanisms underlying TRAIL resistance, particularly concerning death receptor (DR) mRNA stability, remain incompletely understood.
Purpose of the Study:
- To elucidate the molecular mechanisms controlling TRAIL death receptor (DR) mRNA stability.
- To investigate the role of tristetraprolin (TTP) in regulating TRAIL sensitivity in cancer cells.
Main Methods:
- Analysis of AU-rich elements (AREs) in the 3'-untranslated regions (3'-UTRs) of DR4 and DR5 mRNA.
- Assessment of TTP binding to AREs and its effect on DR4/5 mRNA decay.
- Evaluation of TTP's impact on TRAIL sensitivity in colon cancer cells through overexpression and down-regulation studies.
Main Results:
- Tristetraprolin (TTP), an ARE-binding protein, binds to multiple AREs in the 3'-UTRs of DR4 and DR5 mRNA, enhancing their decay.
- TTP overexpression confers TRAIL resistance in colon cancer cells by reducing DR4/5 expression.
- Down-regulation of TTP increases TRAIL sensitivity by upregulating DR4/5 expression.
Conclusions:
- TTP plays a critical role in posttranscriptional regulation of TRAIL death receptors, influencing TRAIL sensitivity in cancer.
- TTP status may serve as a predictive biomarker for TRAIL-based cancer treatments.
More Related Videos
10:50Molecular Modulation by Lentivirus-Delivered Specific shRNAs in Endoplasmic Reticulum Stressed Neurons
Published on: April 24, 2021
09:15Tyramide Signal Amplification for the Immunofluorescent Staining of ZBP1-Dependent Phosphorylation of RIPK3 and MLKL After HSV-1 Infection in Human Cells
Published on: October 20, 2022
Related Concept Videos
GPCR Desensitization
The Extrinsic Apoptotic Pathway
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
The Intrinsic Apoptotic Pathway
Amplifying Signals via Enzymatic Cascade
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...